Abstract
Calcium (Ca2+) has long been recognized as a crucial intracellular messenger attaining stimuli-specific cellular outcomes via localized signaling. Ca2+-binding proteins, such as calmodulin (CaM), and its target proteins are key to the segregation and refinement of these Ca2+-dependent signaling events. This review not only summarizes the recent technological advances enabling the study of subcellular Ca2+-CaM and Ca2+-CaM-dependent protein kinase (CaMKII) signaling events but also highlights the outstanding challenges in the field.
Introduction
Intracellular Ca2+ is a quintessential intracellular messenger, and many of its cellular effects are transduced by calmodulin (CaM). The spatiotemporal characteristics of these intracellular Ca2+ signals hinge on a complex interplay between Ca2+ influx and efflux mechanisms, mobile vs. stationary Ca2+-binding proteins (such as CaM) and intracellular localization/partitioning or sequestration. Over the past decades, great strides have been made in understanding the local control mechanisms underlying the global Ca2+ oscillations (ranging from 0.1 to 1 μM) in the beating heart [1]. It has also become clear that multiple Ca2+ signaling events, independent of those governing cardiac contraction, occur simultaneously in the same myocyte and control myriad cellular outcomes [2]. Several microdomain Ca2+ signals leading to altered transcription have now been identified, e.g., caveolae-localized L-type Ca channels provide the Ca2+ source for the Ca2+-CaM-dependent activation of calcineurin-nuclear factor of activated T cell (NFAT) signaling, and inositol triphosphate receptors (InsP3R) that release Ca2+ can activate Ca2+-CaM-dependent kinase (CaMKII) related to histone deacetylase (HDAC) signaling [3, 4]. Here, we report how recent advances in fluorescent biosensors can provide unique insights into the spatiotemporal dynamics of these local Ca2+-CaM signals, how they are sensed and decoded to shape particular cellular responses.
Calmodulin: a tale of specificity and promiscuity
CaM acts as a pivotal transducer of Ca2+ signals for a wealth of cellular functions including excitation–contraction coupling, metabolism, cell survival, and transcriptional regulation. How CaM regulates such a diversity of signaling pathways with distinct spatial and temporal outcomes remains a central question. Nonetheless, key aspects of CaM signal transduction mechanisms can be explained by the biochemical properties of CaM: its Ca2+-binding properties, localization, concentration and mobility inside the myocyte, and also its binding kinetics to target proteins.
CaM interactions
The three-dimensional crystal structure of Ca2+-free CaM (apoCaM) reveals a dumbbell-like shape (Fig. 1): a flexible, central α helix flanked by two globular lobes (the N- and C-lobes) [5, 6]. Each lobe contains two coupled EF-hand motifs with the C-lobe having higher Ca2+ binding affinity (K d ≈ 1 μM) than the N-lobe (K d ≈ 12 μM) [7–9]. The lobes also differ in Ca2+ dissociation kinetics (∼1,000 s−1for the N-lobe and 100 times slower for the C-lobe). Upon Ca2+ binding, CaM undergoes a profound conformational change (becoming a more elongated structure), modulating the interaction with its target proteins [10]. The structural flexibility of CaM explains the abundance and structural heterogeneity of CaM interacting proteins or interactome [11–14]. These CaM-binding targets differ in their preference for apoCaM, and Ca2+-CaM can be activated or inhibited upon CaM binding and can themselves influence Ca2+ sensitivity of CaM [15, 16]. Target proteins of note in the heart include ion channels (L-type Ca channels (LTCC) [17]), ryanodine receptors (RyR) [18], InsP3R [19], the protein phosphatase calcineurin (CaN) [16], CaMKII, nitric oxide synthase, adenylyl cyclase (AC), phosphodiesterase (PDE), myosin light chain kinase (MLCK), etc. [20].
In vivo, CaM tethering to target proteins can be monitored with fluorescence resonance energy transfer (FRET), even with simultaneous [Ca2+] using Ca2+ indicators [21]. Our group used a variant of this approach in adult cardiac myocytes to map CaM binding to the RyR by monitoring FRET between fluorescently labeled FKBP12.6 bound to RyR and fluorescent CaM [22]. CaM binding was found to stabilize the zipped conformational state of the RyR (reducing RyR activation). Interdomain “unzipping” of the RyR by treating the cells with a peptide DPc10 that mimics one of the zipped regions, also reduced CaM binding and enhanced RyR gating, Ca2+ sparks and waves that favor arrhythmogenic events and unloading Ca2+ from the sarcoplasmic reticulum (SR), thereby mimicking aberrant channel activation as seen in heart failure [23].
CaM (trans)location and availability
Surprisingly, data regarding CaM location and redistribution remain scarce in adult cardiomyocytes. Total CaM concentration is ∼6 μM in isolated cardiac myocytes [24], and at resting [Ca2+] levels, most CaM is apoCaM (not Ca2+ bound). Some of this apoCaM is already prebound to targets as structural elements of the protein or is poised nearby the target awaiting local activation (part of the signaling scaffold). Using null-point titration methods with fluorescently labeled CaM, Wu and Bers found that, as in other cell types, free CaM is around 50–75 nM [25, 26]. That is, only ∼1 % of total CaM is free, which implies that dynamic competition for CaM among its targets is an integral part of the CaM signaling mechanism. In this “limiting CaM” scenario, target proteins with higher Ca2+-CaM affinities (e.g., CaN, PDE, MLCK with K d ≤ 1 nM) will be preferentially activated compared to those targets with lower affinity (e.g., CaMK, AC with K d > 10 nM).
At resting Ca2+ (100 nM [Ca2+] i ), most intracellular CaM is bound to cellular constituents and appears highly localized to the Z line (or transverse tubule) (Fig. 1) [26]. High levels of CaM at the junction between the sarcolemma and SR membrane, where LTCCs and RyRs are both concentrated, facilitate CaM-dependent modulation of both Ca2+ current and SR Ca2+ release. Indeed, such regulatory CaM is already bound to the LTCC and RyR where upon LTCC Ca2+ influx and SR Ca2+ release, locally prebound apoCaM becomes Ca2+-CaM and mediates Ca2+-dependent inactivation of Ca2+ current and favors RyR closure. Thus, Ca-CaM is part of a highly local negative feedback system at the junctional cleft at the heart of excitation–contraction coupling.
Junctional targeting of CaM would likewise facilitate activation of lower CaM affinity targets such as CaMKII, by enhancing the latter’s ability to compete with higher affinity global targets. This may relate to Ca2+-CaM-dependent activation of LTCC via CaMKII activity (Ca2+ current facilitation) in which Ca2+ current amplitude increases (and inactivation slows) in a stepwise manner during increases in stimulation rate [27–29]. This facilitation may help sustain Ca current amplitude at higher heart rates when Ca2+-dependent inactivation might otherwise limit it.
When [Ca2+] is elevated (from 100 to 500 nM), more CaM is bound at the Z lines (where the junctional SR is), and from which CaM dissociation is extremely slow, but there is also a significant translocation of CaM into the nucleus [26]. Normal twitch Ca2+ oscillations did not trigger this nuclear redistribution [4]. This indicated that the kinetics of Ca2+-CaM signaling may be critical for this CaM translocation. Endothelin-1 binding to its G-protein-coupled receptor (GPCR) also causes nuclear translocation of CaM, without triggering a detectable elevation of global [Ca2+] i [4]. Analogous to the RyR environment above, it is possible that CaM at or near InsP3R downstream of endothelin-1 might stimulate this CaM translocation. So, chronic global Ca2+ elevation can trigger nuclear CaM accumulation, but certain local Ca2+ signals can achieve the same effect. Changes in nuclear CaM are likely to be of pathophysiological importance given its regulation of nuclear CaMKII activity (see below), but also because of direct effects on myocyte enhancer factor 2-dependent transcription [30]. In neurons, nuclear CaM was also shown to affect phosphorylation of cAMP response element binding protein [31]. How CaM translocates to the nucleus in cardiomyocytes remains to be identified [32]. In neurons, this nuclear import occurs in association with partner proteins [33], and this is probably also true in the heart given the low free CaM levels (and competition for CaM binding). A more thorough understanding of what type of signals trigger CaM nuclear import could help to clarify things. Another outstanding question is how CaM expression and localization may be altered in cardiac disease. There are conflicting reports regarding CaM expression levels in human heart failure [34, 35] and even less information on CaM localization. Alternatively, association of both apoCaM and Ca2+-CaM with target proteins could be altered. For instance, Ai et al. demonstrated in their rabbit heart failure model that although the total CaM levels were unchanged, CaM association with the RyR was decreased (consistent with increased RyR activity or SR Ca2+ leak) [36]. In that context, if in failing myocytes CaM was found to be redistributed to the nucleus, it could influence gene transcription and alter contractile function in the various etiologies of hypertrophy and heart failure. Gangopadhyay and Ikemoto, albeit in neonatal myocytes, suggested that this might be the case. Here, dantrolene treatment of neonatal myocytes, which ameliorates RyR unzipping and aberrant Ca2+ events following prolonged endothelin-1 exposure, reduced nuclear translocation of CaM and the development of hypertrophy [37].
Concept of “dedicated” vs. “promiscuous” CaM
An emerging theme for CaM modulation of ion channels in cardiac myocytes is the multiple modes of regulation mediated by distinct functional populations of CaM (Fig. 1): a dedicated pool of CaM typically tethered to the channels, which directly regulates channel activity (most often involved in inactivation), and a more promiscuous pool of CaM poised nearby to transduce local Ca2+ signals via activation of downstream effectors such as CaN and CaMKII (providing a negative or positive feedback loop). These intricate levels of CaM regulation of channel function were recently reviewed in detail [38] for the L-type Ca2+ channel, the ryanodine receptor, and the InsP3 receptor but are beyond the scope of this review. In general, the mechanisms of promiscuous CaM regulation are less clear, but from an imaging perspective, several of the remaining questions can be addressed such as: is this promiscuous CaM activated to act locally or does it diffuse from more distant sources? Are the Ca2+signals transduced by the dedicated (tethered) and promiscuous (more global) CaM the same? What is the reservoir/source of this promiscuous CaM pool (e.g., which proteins release CaM with Ca2+ influx)? Several of these events are likely happening within the single resolvable volume of traditional confocal microscopy. The technical challenge to overcome here is the spatial resolution limitation, and this may require novel experimental approaches or a combination thereof: total internal reflection fluorescence microscopy which limits the fluorescence signal to ∼100 nm from the coverslip, FRET imaging of dynamic protein interactions, subcellular targeting of biosensors, super resolution fluorescence microscopy (PALM and STORM).
Dynamics of CaM signals
As mentioned above, CaM target proteins vary greatly in their affinity for CaM (with dissociation constants ranging from 0.1 to >100 nM [39–41]. The Ca2+-CaM affinity of the target protein will determine its Ca2+ dependence (greater for those that bind Ca2+-CaM tightly). The Persechini group developed FRET-based biosensors (BsCaMs) for dynamic measurements in vivo of Ca2+-CaM interaction with CaM target proteins in response to Ca2+ [32, 42–45]. Changes in FRET are detected between the CFP and YFP fluorophores which flank a linker sequence derived from the Ca2+-CaM binding domain of the smooth muscle MLCK (Fig. 2). Site mutations of the linker sequence confer different Ca2+-CaM sensitivities to the sensors [42]. In cardiomyocytes, these sensors can be used to measure the real-time modulation of CaM targets by various Ca2+signals including the beat-to-beat oscillations [24]. Sensors with higher affinity (like CaN) bind Ca2+-CaM more tightly and therefore integrate the rhythmic Ca2+ signals, whereas sensors with lower affinity (like CaMKII) turn on and off more completely with each beat and display only minor integration [46] (Fig. 2). These different behaviors could also be predicted quantitatively from a myocyte model [46, 47] which implies that differences in Ca2+-CaM affinities of CaM target proteins provide an important mechanism for accomplishing the CaM signaling diversity and complexity: Ca-CaM affinity confers specific Ca2+-decoding ability to the CaM target protein thereby fine-tuning the cellular response.
Targeted versions of these biosensors are currently being used by our group to verify model projections of how local CaM signals might regulate CaMKII and CaN [47]. While large Ca2+-CaM oscillations are predicted to occur at the dyadic cleft on a beat-to-beat basis, the extensive CaM buffering and lower cytosolic Ca2+ would minimize the Ca-CaM fluctuations there. For CaMKII, this would mean not only beat-dependent oscillations of activity in the dyadic cleft but also very little activation of CaMKII in the bulk cytosol because of the limited CaM signals in that compartment. It is hard to reconcile this prediction with known CaMKII-dependent phosphorylation of cytosolic targets such as phospholamban, although this may be why CaMKII is routinely anchored nearby its targets—and might have a nearby pool of promiscuous CaM. CaN activity on the other hand is predicted to be frequency dependent in the cytosol and saturated in the dyad. This is consistent with observations that CaN/NFAT signaling correlates closely to global Ca2+ oscillation [48, 49]. Since CaN is tethered to LTCCs [50], it will be important to assess whether CaN activity at the dyad is indeed constitutively active or remains somewhat dynamically regulated by Ca2+ signals.
CaMKII: a multifunctional kinase
While CaMKII is uniquely adapted to sense, integrate, and transduce cellular Ca2+ (and Ca2+-CaM) signals, it is much more than merely a CaM effector. CaMKII is a key regulator of cardiac excitation–contraction coupling via its effects on ion channels and Ca2+ handling proteins, but is also important for more chronic cardiac responses via regulation of gene expression. Aside from this physiological role, CaMKII is also critically involved in the development of arrhythmias and heart failure. Several reviews have highlighted the role of CaMKII in various pathophysiological conditions and its potential as a therapeutic target [51–58].
Biochemistry of CaMKII
CaMKII is unique among protein kinases because it forms a dodecameric holoenzyme. It is encoded by four different genes (α, β, δ, and γ) [59, 60]. Of these, CaMKIIδ is the predominant cardiac isoform, and two splice variants are known to be present in the heart (δB and δC). Each subunit of the holoenzyme consists of a serine/threonine-specific catalytic domain followed by a regulatory segment that binds Ca2+-CaM (Fig. 3). The latter is followed by a flexible linker of variable length (isoform-specific) that connects to the association or hub domain. The association domains assemble the subunits into two stacked hexameric rings. FRET experiments, where the catalytic domain was replaced with CFP or YFP, showed that CaMKII freely hetero-oligomerizes and that the variable linker influences the distance between N-termini [61]. The recent crystal structure of the auto-inhibited CaMKII holoenzyme indicated that this variable linker also provides a fine-tuning mechanism of the holoenzyme Ca2+ response: the variable linker alters the equilibrium between compact and more open docking states of the kinase domains against the central hub (with the CaM binding sites more accessible for the longer linkers) [62]. Indeed, different isoforms display slightly altered sensitivities to Ca2+ [63], but how this translates to signal diversity in the cardiomyocyte remains to be established.
At baseline, CaMKII is in an auto-inhibited state where the catalytic domain is constrained by the pseudosubstrate region within the regulatory domain [64] (Fig. 3a–b). When Ca2+ rises, Ca2+-CaM binds to the regulatory domain of CaMKII and triggers a conformational change that disrupts association with the catalytic domain and exposes an otherwise inaccessible phosphorylation site (T286) [64]. CaMKII deactivates again upon Ca2+-CaM dissociation. During prolonged [Ca2+] elevation, autophosphorylation at T286 prevents reassociation of the regulatory and catalytic domains, resulting in autonomous activity that persists in the absence of Ca2+-CaM [65, 66]. Precisely how CaMKII activity responds to the intensity, duration, and frequency of Ca2+ transients or how acute Ca2+ signaling and GPCR-linked Ca2+ signals are integrated on CaMKII are ongoing research foci. Reactive oxygen species (ROS) can also trigger autonomous CaMKII activity by oxidizing M280/281 residues after initial activation by Ca2+-CaM [67]. Both mishandling of Ca2+ and changes in ROS have been linked to cardiac disease, positioning CaMKII at a key interface [53].
Localization of CaMKII
CaMKII isoforms differ in subcellular targeting as well as interacting partners [68–70] and is purported as a key aspect of isoform signal specificity. In the heart, the CaMKII δB and δC subtypes differ only by the presence of a nuclear localization sequence and are thought to preferentially localize accordingly: δB mainly nuclear and δC mainly cytosolic [71–73]. Different functions had been attributed to each isoform, with nuclear δB involved in hypertrophic gene regulation and cytosolic δC in regulation of ion channels and Ca2+ handling. Initial findings in transgenic mice supported this since CaMKII δB transgenics develop cardiac hypertrophy, but this hypertrophy rapidly transitions to heart failure in the CaMKIIδC mice (with extensive Ca2+ handling dysfunction) [73–77]. However, all CaMKII isoforms (α–δ, including these splice variants) appear to hetero-multimerize [61] which can explain in part why CaMKIIδB is not restricted to the nucleus and CaMKIIδC is not exclusively cytosolic [78]. Indeed, CaMKIIδB and δC were found to have similar effects on MEF2 modulation and gene expression, but initially, this was attributed to direct effects of CaMKIIδB and δC subtypes on HDAC in the nucleus and cytosol, respectively [79]. More recently, Mishra et al. [78] upset this traditional dogma of isoform-specific location and postulated that spatial and functional specificity of CaMKIIδ activation is obtained by mobilization of different Ca2+ stores [78]. This was based on their findings that even when expressed in CaMKIIδ null background, CaMKIIδB and δC subtype targeting remained nonexclusive, and both subtypes had compartment-specific activation profiles: a phenylephrine stimulus triggered nuclear CaMKIIδ activation and HDAC phosphorylation, whereas caffeine elicited cytosolic CaMKIIδ activation and phospholamban phosphorylation. To what extent these findings will impact the notion of CaMKII δB as having a cardioprotective role and δC as having a more deleterious role in cardiomyocyte survival and heart disease [80–83] remains to be established.
It is clear that CaMKII location matters and several direct interactions of CaMKII with target proteins have been described such as with the RyR [74, 84], InsP3R [85], LTCC subunits [28, 29], and mitochondria [86]. Indeed, CaMKII overexpression potentiates SR Ca2+ release and also enhances mitochondrial Ca2+ uptake that can contribute to cell death [87]. Localization poises CaMKII near both local Ca2+ pools and a signaling microdomain, thereby achieving signal specificity (e.g., the InsP3R-CaMKII-HDAC signaling pathway [4]). This direct interaction pattern of CaMKII is in contrast to the scaffolding protein interactions found for PKA (A-kinase anchoring proteins) [88]). However, α kinase anchoring protein was found to serve as an “anchoring” protein for SERCA and CaMKII, positioning CaMKII for modulating PLB phosphorylation [89]. To what extent these interacting proteins modulate CaMKII function is still unclear. In neurons, α-actinin can act as a Ca2+-independent surrogate for CaM binding to CaMKII and also modulates CaMKII phosphorylation of specific substrates (such as glutamate receptor) [90]. In essence, α-actinin acted as a “phosphostat” for a subset of CaMKII targets, maintaining their basal phosphorylation. Other outstanding questions include to what extent CaMKII is translocated in cardiac myocytes and whether CaMKII interactions, localization, and translocation are altered in cardiac disease.
Imaging CaMKII activity and regulation
Until recently, the tools for measuring CaMKII activation in cardiomyocytes were very limited and destructive. These included snapshot measurements of CaMKII modifications (i.e., its autophosphorylation or oxidation state using Western blotting or immunocytochemistry) or CaMKII target phosphorylation and kinase assays in cell lysate (32P incorporations or fluorescence quenching). The Hayashi group developed Camui to study CaMKII activation in neurons [91]. This FRET-based biosensor consists of the full-length kinase flanked by the CFP/YFP fluorophores and takes advantage of the conformational changes of the kinase associated with activation. It is a powerful tool for detecting subtle, subcellular differences in CaMKII activation, so our group adapted it for use in cardiomyocytes [92]. The donor/acceptor fluorescence ratio (F CFP/F YFP) of Camui is a good reporter of CaMKII activation by Ca2+-CaM, autophosphorylation, and oxidation (since all result in an opening of the regulatory and catalytic CaMKII domains). That is, Camui is more than a readout of Ca2+-CaM binding dynamics to cellular CaMKII (which could be inferred from the BsCaM responses), it is a direct readout of the active conformation of the kinase.
It should be noted that although the Camui response is fairly linear over a wide range for autonomous CaMKII activity (via phosphorylation or oxidation), direct Ca2+-CaM activation produces a stronger FRET change for a given amount of enzyme activity. A second limitation is that the Camui FRET is not simple bimolecular FRET but incorporates a structural element (the CFP on the catalytic domain can interact with more than one YFP on the association domain). This may contribute to some nonlinearity in F CFP/F YFP increase as catalytic domains become activated. Nonetheless, Camui is a good proxy for CaMKII activity. It can track both temporal and spatial changes in CaMKII activity in vivo and has the added benefit that the specific contributions of autophosphorylation and oxidation to CaMKII activation can be examined using Camui constructs lacking the target sites for these modifications. This makes Camui uniquely suited to study the subcellular mechanisms driving CaMKII signaling pathways in cardiomyocytes. Indeed, initial experiments showed that while there is a significant role for oxidative activation of CaMKII in response to angiotensin II and endothelin-1 exposure, the isoproterenol- and phenylephrine-triggered activation of CaMKII was largely Ca-CaM and somewhat autophosphorylation dependent.
Camui studies examining the sensitivity of CaMKII function to varying beat-to-beat global Ca2+ signals are already ongoing, as are experiments assessing how CaMKII responds to multiple spatially unique Ca2+ signal inputs (global cytosolic Ca2+ and GPCR-linked signals). Improvements to the Camui sensor also continue to be made [93, 94]: alternate CaMKII isoforms, improved FRET pairs, etc. An alternative to the Camui-style biosensors is a surrogate substrate-based reporter (Kinase Activity Reporter family (KAR), [95]) where a forkhead association domain triggers a molecular switch upon phosphorylation by the target kinase, and this would induce changes in fluorescence intensities of the FRET fluorophores. These KARs have the added benefit that they can be subcellularly targeted to signaling microdomains providing even more detailed spatial information of kinase function. Future studies combining Camui and various models of cardiac disease are likely to provide extensive mechanistic insight into how CaMKII signaling contributes to arrhythmias and heart failure.
Concluding remarks and future perspectives
Numerous studies have shown that Ca2+-CaM-CaMKII signaling has a critical role in the regulation of both acute excitation–contraction and chronic excitation–transcription coupling in the heart. There is also abundant evidence that CaMKII has a ubiquitous role in pathophysiological conditions of the heart. Several fundamental questions regarding the signal processing and spatial intricacies of CaM/CaMKII signaling were highlighted here and deserve further investigation. The new generation of biosensors also provides unique opportunities to delineate the role and regulatory mechanisms of CaM and CaMKII in normal and diseased hearts. This will greatly benefit future efforts to design effective therapeutics targeted at cardiac CaMKII.
References
Bers DM (2001) Excitation-contraction coupling and cardiac contractile force, 2nd edn. Kluwer, Dordrecht
Bers DM (2008) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70:23–49
Makarewich CA, Correll RN, Gao H, Zhang H, Yang B, Berretta RM, Rizzo V, Molkentin JD, Houser SR (2012) A caveolae-targeted L-type Ca2+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res 110:669–674
Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR, Olson EN, Chen J, Brown JH, Bers DM (2006) Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116:675–682
Babu YS, Bugg CE, Cook WJ (1988) Structure of calmodulin refined at 2.2 A resolution. J Mol Biol 204:191–204
Chattopadhyaya R, Meador WE, Means AR, Quiocho FA (1992) Calmodulin structure refined at 1.7 A resolution. J Mol Biol 228:1177–1192
Black DJ, Leonard J, Persechini A (2006) Biphasic Ca2+-dependent switching in a calmodulin-IQ domain complex. Biochemistry 45:6987–6995
Putkey JA, Kleerekoper Q, Gaertner TR, Waxham MN (2003) A new role for IQ motif proteins in regulating calmodulin function. J Biol Chem 278:49667–49670
Faas GC, Mody I (2012) Measuring the kinetics of calcium binding proteins with flash photolysis. Biochim Biophys Acta 1820:1195–1204
Hoeflich KP, Ikura M (2002) Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108:739–742
Black DJ, Persechini A (2011) In calmodulin-IQ domain complexes, the Ca2+-free and Ca2+-bound forms of the calmodulin C-lobe direct the N-lobe to different binding sites. Biochemistry 50:10061–10068
O’Connell DJ, Bauer M, Linse S, Cahill DJ (2011) Probing calmodulin protein–protein interactions using high-content protein arrays. Methods Mol Biol 785:289–303
James P, Vorherr T, Carafoli E (1995) Calmodulin-binding domains: just two faced or multi-faceted? Trends Biochem Sci 20:38–42
Vogel HJ (1994) Calmodulin: a versatile calcium mediator protein. Biochem Cell Biol 72:357–376
Black DJ, LaMartina D, Persechini A (2009) The IQ domains in neuromodulin and PEP19 represent two major functional classes. Biochemistry 48:11766–11772
Stemmer PM, Klee CB (1994) Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 33:6859–6866
Peterson BZ, Lee JS, Mulle JG, Wang Y, de Leon M, Yue DT (2000) Critical determinants of Ca2+-dependent inactivation within an EF-hand motif of L-type Ca2+ channels. Biophys J 78:1906–1920
Balshaw DM, Xu L, Yamaguchi N, Pasek DA, Meissner G (2001) Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem 276:20144–20153
Patel S, Morris SA, Adkins CE, O’Beirne G, Taylor CW (1997) Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci 94:11627–11632
Maier LS, Bers DM (2002) Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J Mol Cell Cardiol 34:919–939
Mori MX, Imai Y, Itsuki K, Inoue R (2011) Quantitative measurement of Ca2+-dependent calmodulin-target binding by Fura-2 and CFP and YFP FRET imaging in living cells. Biochemistry 50:4685–4696
Guo T, Fruen BR, Nitu FR, Nguyen TD, Yang Y, Cornea RL, Bers DM (2011) FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. Biophys J 101:2170–2177
Oda T, Yang Y, Nitu FR, Svensson B, Lu X, Fruen BR, Cornea RL, Bers DM (2013) Binding of RyR2 "unzipping" peptide in cardiomyocytes activates RyR2 and reciprocally inhibits calmodulin binding. Circ Res 112:487–497
Maier LS, Ziolo MT, Bossuyt J, Persechini A, Mestril R, Bers DM (2006) Dynamic changes in free Ca-calmodulin levels in adult cardiac myocytes. J Mol Cell Cardiol 41:451–458
Persechini A, Stemmer PM (2002) Calmodulin is a limiting factor in the cell. Trends Cardiovasc Med 12:32–37
Wu X, Bers DM (2007) Free and bound intracellular calmodulin measurements in cardiac myocytes. Cell Calcium 41:353–364
Hryshko LV, Bers DM (1990) Ca current facilitation during postrest recovery depends on Ca entry. Am J Physiol 259:H951–961
Grueter CE, Abiria SA, Dzhura I, Wu Y, Ham AJ, Mohler PJ, Anderson ME, Colbran RJ (2006) L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell 23:641–650
Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS (2005) CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol 171:537–547
Berger I, Bieniossek C, Schaffitzel C, Hassler M, Santelli E, Richmond TJ (2003) Direct interaction of Ca2+/calmodulin inhibits histone deacetylase 5 repressor core binding to myocyte enhancer factor 2. J Biol Chem 278:17625–17635
Mermelstein PG, Deisseroth K, Dasgupta N, Isaksen AL, Tsien RW (2001) Calmodulin priming: nuclear translocation of a calmodulin complex and the memory of prior neuronal activity. Proc Natl Acad Sci 98:15342–15347
Teruel MN, Chen W, Persechini A, Meyer T (2000) Differential codes for free Ca2+-calmodulin signals in nucleus and cytosol. Curr Biol 10:86–94
Thorogate R, Torok K (2004) Ca2+-dependent and -independent mechanisms of calmodulin nuclear translocation. J Cell Sci 117:5923–5936
Jeck CD, Zimmermann R, Schaper J, Schaper W (1994) Decreased expression of calmodulin mRNA in human end-stage heart failure. J Mol Cell Cardiol 26:99–107
Cortes R, Rivera M, Rosello-Lleti E, Martinez-Dolz L, Almenar L, Azorin I, Lago F, Gonzalez-Juanatey JR, Portoles M (2012) Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One 7:e30915
Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM (2005) Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 97:1314–1322
Gangopadhyay JP, Ikemoto N (2010) Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes. Biochem Biophys Res Commun 396:515–521
Saucerman JJ, Bers DM (2012) Calmodulin binding proteins provide domains of local Ca2+ signaling in cardiac myocytes. J Mol Cell Cardiol 52:312–316
Cohen P, Klee CB (1988) Calmodulin. Elsevier, Amsterdam
Hubbard MJ, Klee CB (1987) Calmodulin binding by calcineurin. Ligand-induced renaturation of protein immobilized on nitrocellulose. J Biol Chem 262:15062–15070
Davis BA, Schwartz A, Samaha FJ, Kranias EG (1983) Regulation of cardiac sarcoplasmic reticulum calcium transport by calcium-calmodulin-dependent phosphorylation. J Biol Chem 258:13587–13591
Persechini A, Cronk B (1999) The relationship between the free concentrations of Ca2+ and Ca2+-calmodulin in intact cells. J Biol Chem 274:6827–6830
Romoser VA, Hinkle PM, Persechini A (1997) Detection in living cells of Ca2+-dependent changes in the fluorescence emission of an indicator composed of two green fluorescent protein variants linked by a calmodulin-binding sequence. A new class of fluorescent indicators. J Biol Chem 272:13270–13274
Tran QK, Black DJ, Persechini A (2003) Intracellular coupling via limiting calmodulin. J Biol Chem 278:24247–24250
Tran QK, Black DJ, Persechini A (2005) Dominant affectors in the calmodulin network shape the time courses of target responses in the cell. Cell Calcium 37:541–553
Song Q, Saucerman JJ, Bossuyt J, Bers DM (2008) Differential integration of Ca2+-calmodulin signal in intact ventricular myocytes at low and high affinity Ca2+-calmodulin targets. J Biol Chem 283:31531–31540
Saucerman JJ, Bers DM (2008) Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes. Biophys J 95:4597–4612
Tavi P, Pikkarainen S, Ronkainen J, Niemela P, Ilves M, Weckstrom M, Vuolteenaho O, Bruton J, Westerblad H, Ruskoaho H (2004) Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression. J Physiol 554:309–320
Colella M, Grisan F, Robert V, Turner JD, Thomas AP, Pozzan T (2008) Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc Natl Acad Sci U S A 105:2859–2864
Tandan S, Wang Y, Wang TT, Jiang N, Hall DD, Hell JW, Luo X, Rothermel BA, Hill JA (2009) Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel. Circ Res 105:51–60
Banyasz T, Szentandrassy N, Toth A, Nanasi PP, Magyar J, Chen-Izu Y (2011) Cardiac calmodulin kinase: a potential target for drug design. Curr Med Chem 18:3707–3713
Dominguez-Rodriguez A, Ruiz-Hurtado G, Benitah JP, Gomez AM (2012) The other side of cardiac Ca2+ signaling: transcriptional control. Front Physiol 3:452
Erickson JR, He BJ, Grumbach IM, Anderson ME (2011) CaMKII in the cardiovascular system: sensing redox states. Physiol Rev 91:889–915
Fischer TH, Neef S, Maier LS (2013) The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies? J Mol Cell Cardiol 58:182–187
Maier LS (2012) Ca2+/calmodulin-dependent protein kinase II (CaMKII) in the heart. Adv Exp Med Biol 740:685–702
Rokita AG, Anderson ME (2012) New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII). Circulation 126:2125–2139
Singh MV, Anderson ME (2011) Is CaMKII a link between inflammation and hypertrophy in heart? J Mol Med (Berl) 89:537–543
Swaminathan PD, Purohit A, Hund TJ, Anderson ME (2012) Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 110:1661–1677
Tombes RM, Faison MO, Turbeville JM (2003) Organization and evolution of multifunctional Ca2+/CaM-dependent protein kinase genes. Gene 322:17–31
Hudmon A, Schulman H (2002) Neuronal Ca2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473–510
Lantsman K, Tombes RM (2005) CaMK-II oligomerization potential determined using CFP/YFP FRET. Biochim Biophys Acta 1746:45–54
Chao LH, Pellicena P, Deindl S, Barclay LA, Schulman H, Kuriyan J (2010) Intersubunit capture of regulatory segments is a component of cooperative CaMKII activation. Nat Struct Mol Biol 17:264–272
De Koninck P, Schulman H (1998) Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 279:227–230
Hoffman L, Stein RA, Colbran RJ, McHaourab HS (2011) Conformational changes underlying calcium/calmodulin-dependent protein kinase II activation. EMBO J 30:1251–1262
Schworer CM, Colbran RJ, Keefer JR, Soderling TR (1988) Ca2+/calmodulin-dependent protein kinase II. Identification of a regulatory autophosphorylation site adjacent to the inhibitory and calmodulin-binding domains. J Biol Chem 263:13486–13489
Rellos P, Pike AC, Niesen FH, Salah E, Lee WH, von Delft F, Knapp S (2010) Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation. PLoS Biol 8:e1000426
Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O’Donnell SE, Aykin-Burns N et al (2008) A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133:462–474
Liu XB, Murray KD (2012) Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia 53(Suppl 1):45–52
Colbran RJ (2004) Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J 378:1–16
Skelding KA, Rostas JA (2009) Regulation of CaMKII in vivo: the importance of targeting and the intracellular microenvironment. Neurochem Res 34:1792–1804
Edman CF, Schulman H (1994) Identification and characterization of delta B-CaM kinase and delta C-CaM kinase from rat heart, two new multifunctional Ca2+/calmodulin-dependent protein kinase isoforms. Biochim Biophys Acta 1221:89–101
Srinivasan M, Edman CF, Schulman H (1994) Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus. J Cell Biol 126:839–852
Ramirez MT, Zhao XL, Schulman H, Brown JH (1997) The nuclear deltaB isoform of Ca2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem 272:31203–31208
Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, Bers DM, Brown JH (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92:912–919
Zhang T, Johnson EN, Gu Y, Morissette MR, Sah VP, Gigena MS, Belke DD, Dillmann WH, Rogers TB, Schulman H et al (2002) The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 277:1261–1267
Wagner S, Dybkova N, Rasenack EC, Jacobshagen C, Fabritz L, Kirchhof P, Maier SK, Zhang T, Hasenfuss G, Brown JH et al (2006) Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na + channels. J Clin Invest 116:3127–3138
Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM (2003) Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 92:904–911
Mishra S, Gray CB, Miyamoto S, Bers DM, Brown JH (2011) Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ Res 109:1354–1362
Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N, Chang S, Ling H, Bers DM, Maier LS et al (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282:35078–35087
Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP (2007) Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 282:10833–10839
Peng W, Zhang Y, Zheng M, Cheng H, Zhu W, Cao CM, Xiao RP (2010) Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res 106:102–110
Little GH, Saw A, Bai Y, Dow J, Marjoram P, Simkhovich B, Leeka J, Kedes L, Kloner RA, Poizat C (2009) Critical role of nuclear calcium/calmodulin-dependent protein kinase II deltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem 284:24857–24868
Mishra S, Ling H, Grimm M, Zhang T, Bers DM, Brown JH (2010) Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J Cardiovasc Pharmacol 56:598–603
Hain J, Onoue H, Mayrleitner M, Fleischer S, Schindler H (1995) Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem 270:2074–2081
Bare DJ, Kettlun CS, Liang M, Bers DM, Mignery GA (2005) Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem 280:15912–15920
Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B et al (2012) CaMKII determines mitochondrial stress responses in heart. Nature 491:269–273
Zhang T, Guo T, Mishra S, Dalton ND, Kranias EG, Peterson KL, Bers DM, Brown JH (2010) Phospholamban ablation rescues sarcoplasmic reticulum Ca2+ handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice. Circ Res 106:354–362
Diviani D, Dodge-Kafka KL, Li J, Kapiloff MS (2011) A-kinase anchoring proteins: scaffolding proteins in the heart. Am J Physiol Heart Circ Physiol 301:H1742–1753
Singh P, Salih M, Tuana BS (2009) Alpha-kinase anchoring protein alphaKAP interacts with SERCA2A to spatially position Ca2+/calmodulin-dependent protein kinase II and modulate phospholamban phosphorylation. J Biol Chem 284:28212–28221
Jalan-Sakrikar N, Bartlett RK, Baucum AJ 2nd, Colbran RJ (2012) Substrate-selective and calcium-independent activation of CaMKII by alpha-actinin. J Biol Chem 287:15275–15283
Takao K, Okamoto K, Nakagawa T, Neve RL, Nagai T, Miyawaki A, Hashikawa T, Kobayashi S, Hayashi Y (2005) Visualization of synaptic Ca2+ /calmodulin-dependent protein kinase II activity in living neurons. J Neurosci 25:3107–3112
Erickson JR, Patel R, Ferguson A, Bossuyt J, Bers DM (2011) Fluorescence resonance energy transfer-based sensor Camui provides new insight into mechanisms of calcium/calmodulin-dependent protein kinase II activation in intact cardiomyocytes. Circ Res 109:729–738
Kwok S, Lee C, Sanchez SA, Hazlett TL, Gratton E, Hayashi Y (2008) Genetically encoded probe for fluorescence lifetime imaging of CaMKII activity. Biochem Biophys Res Commun 369:519–525
Lam AJ, St-Pierre F, Gong Y, Marshall JD, Cranfill PJ, Baird MA, McKeown MR, Wiedenmann J, Davidson MW, Schnitzer MJ et al (2012) Improving FRET dynamic range with bright green and red fluorescent proteins. Nat Methods 9:1005–1012
Zhang J, Allen MD (2007) FRET-based biosensors for protein kinases: illuminating the kinome. Mol Biosyst 3:759–765
Acknowledgments
This study was funded by NIH P01-HL080101 (DMB & JB), R37-HL30077 (DMB), and R01-130933 (JB).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Both authors contributed equally to the writing of this review article.
Rights and permissions
About this article
Cite this article
Bossuyt, J., Bers, D.M. Visualizing CaMKII and CaM activity: a paradigm of compartmentalized signaling. J Mol Med 91, 907–916 (2013). https://doi.org/10.1007/s00109-013-1060-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-013-1060-y